3-[(Benzenesulfonyl)methyl]-5-(3-methoxyphenyl)-1,2,4-oxadiazole

Catalog No. :
ACJLQQ202
CAS No. :
672925-67-6
Molecular Formula :
C16H14N2O4S
Molecular Weight :
330.36

IUPAC Name:5-(3-methoxyphenyl)-3-((phenylsulfonyl)methyl)-1,2,4-oxadiazole

3-[(Benzenesulfonyl)methyl]-5-(3-methoxyphenyl)-1,2,4-oxadiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-[(Benzenesulfonyl)methyl]-5-(3-methoxyphenyl)-1,2,4-oxadiazole
IUPAC Name5-(3-methoxyphenyl)-3-((phenylsulfonyl)methyl)-1,2,4-oxadiazole
MDL No.MFCD02186683
Molecular FormulaC16H14N2O4S
Molecular Weight330.36
SMILESCOC1=CC(C2=NC(CS(=O)(C3=CC=CC=C3)=O)=NO2)=CC=C1
InChI KeyAYNUMQDLXZSVHG-UHFFFAOYSA-N
Synonym[5-(3-METHOXYPHENYL)-1,2,4-OXADIAZOL-3-YL]METHYL PHENYL SULFONE;5-(3-METHOXYPHENYL)-3-[(PHENYLSULFONYL)METHYL]-1,2,4-OXADIAZOLE;3-[(benzenesulfonyl)methyl]-5-(3-methoxyphenyl)-1,2,4-oxadiazole;1,2,4-Oxadiazole, 5-(3-methoxyphenyl)-3-[(phenylsulfonyl)methyl]-
CAS No.672925-67-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACJLQQ202 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJLQQ202 route product structure diagram
    ACJLQQ202672925-67-6
Inquiry

2. ACJLQQ202 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUXIA380 route compound structure diagram
    ACUXIA38025932-11-0 In Stock
  4. Then
  5. ACJLQQ202 route product structure diagram
    ACJLQQ202672925-67-6
Inquiry

Comments (0)